equity (times) 1.1 0.9 1.1 Net debt to EBITDA (times) 0.9 0.9 1.0 Net debt & lease liability & spectrum license payable to EBITDA 2.3 2.2 2.2 Current Ratio (times) 0.4 0.4 0.3 Interest Coverage (times
equity (times) 1.1 0.9 1.1 Net debt to EBITDA (times) 0.9 0.9 1.0 Net debt & lease liability & spectrum license payable to EBITDA 2.3 2.2 2.2 Current Ratio (times) 0.4 0.4 0.3 Interest Coverage (times
1.0 Net debt & lease liability & spectrum license payable to EBITDA 2.3 2.2 2.2 Current Ratio (times) 0.4 0.4 0.3 Interest Coverage (times) 15.7 15.7 14.8 Debt Service Coverage Ratio (times) 4.2 3.2 2.1
TFRS-15) Total asset was Bt283,593mn in 3Q19, decreased by 2.4% from 4Q18 as spectrum licenses had been amortized. However, some of the effect was negated by an increase in cash. Current liability
TFRS-15) Total asset was Bt283,593mn in 3Q19, decreased by 2.4% from 4Q18 as spectrum licenses had been amortized. However, some of the effect was negated by an increase in cash. Current liability
0.8 Net debt & lease liability & spectrum license payable to EBITDA 2.2 2.2 2.0 Current Ratio (times) 0.4 0.3 0.4 Interest Coverage (times) 16.0 14.8 15.9 Debt Service Coverage Ratio (times) 4.4 2.1 3.1
: Million Baht) Consolidated Separate Y2017 + Increased /-Decreased Y2017 + Increased /-Decreased Brokerage fees income 592.30 (28.82) 592.30 (28.82) Fees and service income 38.75 (16.45) 38.75 (16.45
previous year 7.62%. Income from medical treatments in the separate financial statement went up 4.79% due to the increased in the number of out-patients to 2.57% but the decreased in the number of in
process has been delayed from the planned schedule, which may indicate potential impairment of assets related to the SPAC structure investments in the separate financial statements, such as investments in
, decrease by 178.48 million baht or 79.51 percent and had a net loss from separate financial statement of 35.50 million baht when comparison with the same period at the last year loss, decreased by 183.12